BLUE - bluebird bio, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1691618
Avg. Estimate-1.67-1.7-6.8-6.9
Low Estimate-1.94-2.03-7.03-8.62
High Estimate-0.78-0.92-5.91-3.53
Year Ago EPS-1.88-1.68-7.07-6.8
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1581618
Avg. Estimate6.8M6.05M38.98M30.3M
Low EstimateN/A1.2M31.26M13M
High Estimate12M9.3M53.07M79M
Year Ago Sales1.55M6.83M6.16M38.98M
Sales Growth (year/est)338.10%-11.40%533.30%-22.30%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-1.86-1.78-1.66-1.71
EPS Actual-1.88-1.68-1.73-1.73
Difference-0.020.1-0.07-0.02
Surprise %-1.10%5.60%-4.20%-1.20%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-1.67-1.7-6.8-6.9
7 Days Ago-1.67-1.7-6.78-6.88
30 Days Ago-1.77-1.78-6.8-7.09
60 Days Ago-1.74-1.68-6.84-6.96
90 Days Ago-1.7-1.65-6.78-6.84
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1361214
Down Last 30 DaysN/AN/A11
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesBLUEIndustrySectorS&P 500
Current Qtr.11.20%N/AN/A0.26
Next Qtr.-1.20%N/AN/A0.27
Current Year3.80%N/AN/A0.08
Next Year-1.50%N/AN/A0.12
Next 5 Years (per annum)162.00%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A